✦ LIBER ✦

PCN80 COST-EFFECTIVENESS ANALYSIS OF OXLIPLATIN IN ADJUVANT THERAPY FOR STAGE 3 COLON CANCER PATIENTS IN JAPAN

✍ Scribed by T Fukuda; T Shiroiwa; T Takeuchi; K Shimozuma; Y Ohashi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Adjuvant FOLFOX Th

✍ Takeru Shiroiwa; Toshihiro Takeuchi; Takashi Fukuda; Kojiro Shimozuma; Yasuo Oha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 777 KB

PCN59 REAL-WORLD COSTS OF ADJUVANT TREAT

✍ CWM van Gils; SS Tan; WK Redekop; CJA Punt 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCN22 IS CAPECITABINE A COST-EFFECTIVE A

✍ MC Orchard; J Hoch; SMH Alibhai 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCN13 COST-EFFECTIVENESS OF ADJUVANT CAP

✍ P Tilleul; G Perrocheau; A Lafuma; E Roux 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PCN39 EXPLORATORY COST EFFECTIVENESS ANA

✍ P Ducournau; N Latimer; E Sabate; S Walzer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

PCN7 COST-EFFECTIVENESS ANALYSIS OF ADJU

✍ E Orlewska; T Pienkowski; K Drosik; M Gyldmark; R Aultman; M Szkultecka-Debek 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB